Stay updated on Immunotherapy in Surgically Resectable HNSCC Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy in Surgically Resectable HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy in Surgically Resectable HNSCC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:39:57.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change likely represents an update or modification in the context of a clinical trial study involving immunotherapy for head and neck squamous cell carcinoma after adjuvant therapy.
    Difference
    0.1%
    Check dated 2024-06-06T14:41:05.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to provide a detailed explanation of eligibility criteria, including examples such as general health condition or prior treatments. The new description also directs users to 'Learn About Studies' for general information about clinical research.
    Difference
    43%
    Check dated 2024-05-22T21:26:17.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:31:06.000Z thumbnail image

Stay in the know with updates to Immunotherapy in Surgically Resectable HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy in Surgically Resectable HNSCC Clinical Trial page.